Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma.

Publication Year: 2024

DOI:
10.21037/tcr-23-1383

PMCID:
PMC10894348

PMID:
38410230

Journal Information

Full Title: Transl Cancer Res

Abbreviation: Transl Cancer Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-1383/coif). The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: This research was supported by the Medical Science and Technology Research Foundation of Guangdong Province ( grant No. A2022232 ), and Foshan Nanhai District “14th Five-Year Plan” key specialty (special specialty) construction project ."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025